We are live on ! Find out more

2,018 hedge funds and large institutions have $120B invested in Merck in 2018 Q2 according to their latest regulatory filings, with 120 funds opening new positions, 780 increasing their positions, 868 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 77

37% more funds holding in top 10

Funds holding in top 10: 84115 (+31)

10% more call options, than puts

Call options by funds: $1.22B | Put options by funds: $1.1B

10% more capital invested

Capital invested by funds: $110B → $120B (+$10.7B)

1% more funds holding

Funds holding: 1,9932,018 (+25)

0.83% less ownership

Funds ownership: 78.21%77.38% (-0.83%)

10% less repeat investments, than reductions

Existing positions increased: 780 | Existing positions reduced: 868

Holders
2,018
Holders Change
+25
Holders Change %
+1.25%
% of All Funds
46.19%
Holding in Top 10
115
Holding in Top 10 Change
+31
Holding in Top 10 Change %
+36.9%
% of All Funds
2.63%
New
120
Increased
780
Reduced
868
Closed
77
Calls
$1.22B
Puts
$1.1B
Net Calls
+$112M
Net Calls Change
-$116M
Name Holding Trade Value Shares
Change
Change in
Stake
Man Group
351
Man Group
United Kingdom
$20.1M +$1.04M +18,391 +6%
CWG
352
C WorldWide Group
Denmark
$20M +$7.64M +135,337 +64%
Creative Planning
353
Creative Planning
Kansas
$19.8M +$576K +10,212 +3%
NAM
354
Nissay Asset Management
Japan
$19.5M -$1.18M -20,832 -6%
CIP
355
Chartwell Investment Partners
Pennsylvania
$19.4M +$2.52M +44,701 +15%
WPC
356
Waters Parkerson & Co
Louisiana
$19.3M +$174K +3,085 +0.9%
ISL
357
Ingalls & Snyder LLC
New York
$19.3M -$64.1K -1,137 -0.3%
RA
358
Rovida Advisors
Florida
$19.2M
NC
359
Nicholas Company
Wisconsin
$19.2M +$9.36M +165,971 +100%
DCM
360
Dupont Capital Management
Delaware
$19.2M -$1.88M -33,314 -9%
AJ
361
Ashburton (Jersey)
Jersey
$19.1M +$312K +5,539 +2%
CBOA
362
Commonwealth Bank of Australia
Australia
$19.1M +$2.55M +45,182 +16%
CCMD
363
Cypress Capital Management (Delaware)
Delaware
$18.8M +$899K +15,930 +5%
KA
364
KLCM Advisors
Wisconsin
$18.4M -$172K -3,055 -1%
APSP
365
Asset Planning Services (Pennsylvania)
Pennsylvania
$18.3M -$2.06M -36,552 -10%
Rockefeller Capital Management
366
Rockefeller Capital Management
New York
$18.2M -$6.57M -116,518 -27%
CL
367
Chubb Ltd
Switzerland
$18.2M
CIM
368
Corda Investment Management
Texas
$18.1M +$7.17K +127 +0%
OPERF
369
Oregon Public Employees Retirement Fund
Oregon
$17.9M +$89.1K +1,579 +0.5%
Northwestern Mutual Wealth Management
370
Northwestern Mutual Wealth Management
Wisconsin
$17.9M -$2.2M -38,930 -11%
AIM
371
Achmea Investment Management
Netherlands
$17.6M -$1.02M -18,108 -6%
ELI
372
Empire Life Investments
Ontario, Canada
$17.5M +$81.1K +1,437 +0.5%
6M
373
6 Meridian
Kansas
$17.5M -$333K -5,904 -2%
CEP
374
Chicago Equity Partners
Illinois
$17.4M +$4.12M +72,988 +32%
OC
375
Oppenheimer & Co
New York
$17.3M +$222K +3,941 +1%

MRK Hedge Fund Activity: Q2 2018 in Review

2,018 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2018, worth a combined $120B — up 9.7% from $110B a quarter earlier.

Buyers outnumbered sellers: 120 funds opened new MRK positions and 77 closed out — a net gain of 43 holders — while 780 added to existing stakes and 868 trimmed.

The largest buyer was Capital World Investors, adding an estimated $904M. The largest seller was Dodge & Cox, cutting an estimated $620M.

  • 2,018 institutional investors held Merck (MRK) as of Q2 2018, up from 1,993 in Q1 2018.
  • Funds reported $120B of Merck stock for Q2 2018, up 9.7% quarter-over-quarter.
  • 120 funds opened new Merck positions in Q2 2018 and 77 closed out, a net change of +43 holders.
  • The largest Merck buyer in Q2 2018 was Capital World Investors, an estimated $904M added.
  • The largest Merck seller in Q2 2018 was Dodge & Cox, an estimated $620M sold.

Based on aggregated 13F filings for Q2 2018.